Effect of an Oral Supplement on the Total Energy and Protein Intake of Head and Neck Cancer Patients in the Last 2 Weeks of Radiation Therapy
Efficacy of an Oral Nutrition Supplement on the Total Caloric and Protein Intake of Head and Neck Cancer Patients During the Last 2 Weeks of Radiation Therapy
1 other identifier
interventional
N/A
0 countries
N/A
Brief Summary
In this study, an oral nutrition supplement has been developed that take into consideration: the nutritional requirements, treatment side-effects and taste preferences of head and neck cancer patients; the acceptance of a supplement when experiencing radiation therapy side-effects; and the taste preferences of head and neck cancer patients which may affect the supplement intake. We hope to increase dietary intake during the last 2 weeks of radiation therapy.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
Started Nov 2006
Typical duration for not_applicable head-and-neck-cancer
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
September 11, 2006
CompletedFirst Posted
Study publicly available on registry
September 13, 2006
CompletedStudy Start
First participant enrolled
November 1, 2006
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 1, 2010
CompletedStudy Completion
Last participant's last visit for all outcomes
January 1, 2010
CompletedFebruary 25, 2016
March 1, 2012
3.2 years
September 11, 2006
February 24, 2016
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
total energy and protein intake
Study completion
Interventions
Eligibility Criteria
You may qualify if:
- years or older
- diagnosed with head and neck cancer including the lip, oral cavity, salivary glands, paranasal sinuses, oropharynx, nasopharynx, hypopharynx, larynx and thyroid.
- all histologic types of cancer
- all tumour stages according to American Joint Committee for Cancer (AJCC) Staging
- all forms of RT including standard or investigational for head and neck cancers
- alert and mentally competent
- English speaking
You may not qualify if:
- an allergy or intolerance to any of the substances used in the nutrition supplement
- Type I or II diabetes mellitus
- renal insufficiency
- unable to swallow
- additional criteria of all forms of chemotherapy standard or investigational or combination of radiation/chemotherapy standard or investigational for head and neck cancers
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- AHS Cancer Control Albertalead
- Cross Cancer Institutecollaborator
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Cathy Kubrak, PhD
University of Alberta
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NON RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
September 11, 2006
First Posted
September 13, 2006
Study Start
November 1, 2006
Primary Completion
January 1, 2010
Study Completion
January 1, 2010
Last Updated
February 25, 2016
Record last verified: 2012-03